Skip to content

Prepaid expenses at other companies

Schrodinger logo
SchrodingerSDGR
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
Arrowhead Research logo
Arrowhead ResearchARWR
XER
Xeris Biopharma Holdings, Inc.XERS
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Lantheus Holdings logo
Lantheus HoldingsLNTH

Other financials

Income statement

See full
Revenue$6.5M-56.1%
Gross profit-$6.0M+15.0%
Operating income-$128.5M+32.8%
Net income-$117.5M+42.0%
EPS (diluted)-$0.22+56.0%

Balance sheet

See full
Cash & equivalents$665.2M+30.6%
Total debt$88.6M-24.6%
Total equity$1.0B+9.7%
Total assets$1.3B+2.6%

Cash flow

See full
Operating cash flow-$81.1M+38.5%
CapEx$258.0K-85.9%
Free cash flow-$81.4M+39.2%

Valuation

See full
Market cap$1.71B-23.7%
Enterprise value$1.14B-39.8%
P/S25.8×-11.8×

Profitability

See full
Gross margin7.2%
Operating margin-881.3%-66.8pp
Net margin-842.9%-92.4pp
FCF margin-490.7%-102pp

Returns & leverage

See full
Return on equity-57.2%-14.4pp
Debt / equity0.1×0.0×
Current ratio5.5×+1.4×

Where this comes from

Reported directly by Recursion Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s prepaid expenses?
Recursion Pharmaceuticals, Inc. (RXRX) reported prepaid expenses of $11.74M in Q1 2026.
How has Recursion Pharmaceuticals, Inc.'s prepaid expenses changed year-over-year?
Recursion Pharmaceuticals, Inc.'s prepaid expenses increased by 375.4% year-over-year, from $2.47M to $11.74M.